0002107977-26-000001.txt : 20260130 0002107977-26-000001.hdr.sgml : 20260130 20260130164947 ACCESSION NUMBER: 0002107977-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260130 DATE AS OF CHANGE: 20260130 EFFECTIVENESS DATE: 20260130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Navega Therapeutics, Inc. CENTRAL INDEX KEY: 0002107977 ORGANIZATION NAME: EIN: 830969353 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-571986 FILM NUMBER: 26584145 BUSINESS ADDRESS: STREET 1: 3210 MERRYFIELD ROW CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-242-1578 MAIL ADDRESS: STREET 1: 3210 MERRYFIELD ROW CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0002107977 Navega Therapeutics, Inc. 3210 MERRYFIELD ROW SAN DIEGO CA CALIFORNIA 92121 858-242-1578 DELAWARE None None Corporation true Ana Moreno 3210 Merryfield Row San Diego CA CALIFORNIA 92121 Executive Officer Director Fernando Aleman 3210 Merryfield Row San Diego CA CALIFORNIA 92121 Executive Officer Director Randy Socol 3210 Merryfield Row San Diego CA CALIFORNIA 92121 Executive Officer Biotechnology Decline to Disclose 06b false 2026-01-02 false true false 0 2500000 1300000 1200000 true 1 8 0 0 0 false Navega Therapeutics, Inc. /s/ Ana Moreno Ana Moreno Chief Executive Officer 2026-01-30